StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note released on Sunday. The brokerage issued a hold rating on the specialty ...

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest ...

The FDA has approved a supplemental New Drug Application (sNDA) for Cumberland Pharmaceuticals Inc.’s Acetadote (N-acetylcysteine for injection) product, an intravenous (IV) formulation of ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...

Acetadote is supplied as a 20% solution (200mg/mL) in a 30mL single-dose vial that must be diluted prior to intravenous administration. Total injection volume will vary based on the patient’s ...

The Food and Drug Administration (FDA) has approved a new dosing regimen for Acetadote ® (n-acetylcysteine [NAC] for injection), an antidote for acetaminophen overdose. According to Cumberland ...

AI can spot patterns in the data from blood tests that can give an early warning of disease. AI is trained to spot warning signs in blood tests AI can spot patterns in the data from blood tests ...

Cumberland Pharmaceuticals' stock is one of the leading gainers today, surging over 90% in value. Moreover, in the past month we've seen the stock jumping a whopping 101%. Cumberland Stock Soars ...

FDA approved a simplified Acetadote dosing regimen, reducing errors and serious reactions while maintaining effectiveness. Acetadote addresses liver injury from acetaminophen toxicity, the leading ...